OM:NGS

Stock Analysis Report

Executive Summary

NGS Group AB (publ) operates as a staffing and consulting company in the healthcare, school, social services, finance, management, and leadership areas in Sweden, Norway, and Finland.

Snowflake

Fundamentals

Undervalued with adequate balance sheet.


Similar Companies

Share Price & News

How has NGS Group's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-1.8%

NGS

2.7%

SE Healthcare

1.9%

SE Market


1 Year Return

-30.6%

NGS

-7.9%

SE Healthcare

9.6%

SE Market

Return vs Industry: NGS underperformed the Swedish Healthcare industry which returned -7.9% over the past year.

Return vs Market: NGS underperformed the Swedish Market which returned 9.6% over the past year.


Shareholder returns

NGSIndustryMarket
7 Day-1.8%2.7%1.9%
30 Day-1.8%1.4%-0.3%
90 Day-6.5%4.3%0.7%
1 Year-27.4%-30.6%-6.6%-7.9%14.3%9.6%
3 Year-45.5%-52.2%-18.8%-22.7%31.5%11.9%
5 Year-2.9%-20.7%167.5%129.1%66.2%30.8%

Price Volatility Vs. Market

How volatile is NGS Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is NGS Group undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Undervalued: NGS (SEK21.5) is trading below our estimate of fair value (SEK46.66)

Significantly Undervalued: NGS is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: NGS is good value based on its PE Ratio (9.5x) compared to the Healthcare industry average (26.8x).

PE vs Market: NGS is good value based on its PE Ratio (9.5x) compared to the Swedish market (16.7x).


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate NGS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: NGS is good value based on its PB Ratio (0.9x) compared to the SE Healthcare industry average (1.4x).


Next Steps

Future Growth

How is NGS Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

1.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: NGS's forecast earnings growth (1.5% per year) is above the savings rate (0.4%).

Earnings vs Market: NGS's earnings (1.5% per year) are forecast to grow slower than the Swedish market (8.9% per year).

High Growth Earnings: NGS's earnings are forecast to grow, but not significantly.

Revenue vs Market: Insufficient data to determine if NGS's revenue is forecast to grow faster than the Swedish market.

High Growth Revenue: Insufficient data to determine if NGS's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: Insufficient data to determine if NGS's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has NGS Group performed over the past 5 years?

3.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: NGS's earnings have grown by 3% per year over the past 5 years.

Accelerating Growth: NGS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: NGS had negative earnings growth (-52%) over the past year, making it difficult to compare to the Healthcare industry average (-15.7%).


Return on Equity

High ROE: NGS's Return on Equity (9.4%) is considered low.


Return on Assets

ROA vs Industry: NGS has a higher Return on Assets than the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: NGS's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is NGS Group's financial position?


Financial Position Analysis

Short Term Liabilities: NGS's short term assets (SEK100.9M) do not cover its short term liabilities (SEK110.3M)

Long Term Liabilities: NGS's short term assets (100.9M) exceeds its long term liabilities (12.1M)


Debt to Equity History and Analysis

Debt Level: NGS's debt to equity ratio (21.4%) is considered satisfactory

Reducing Debt: NGS's debt to equity ratio has increased from 2.4% to 21.4% over the past 5 years.

Debt Coverage: NGS's debt is well covered by operating cash flow (58.3%).

Interest Coverage: NGS's interest payments on its debt are well covered by EBIT (24.1x coverage).


Balance Sheet

Inventory Level: NGS has a low level of unsold assets or inventory.

Debt Coverage by Assets: NGS's debt is covered by short term assets (assets are 2.178690x debt).


Next Steps

Dividend

What is NGS Group's current dividend yield, its reliability and sustainability?

4.65%

Current Dividend Yield


Dividend Yield vs Market

company4.7%marketbottom25%1.8%markettop25%4.8%industryaverage1.7%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: NGS's dividend (4.65%) is higher than the bottom 25% of dividend payers in the Swedish market (1.79%).

High Dividend: NGS's dividend (4.65%) is low compared to the top 25% of dividend payers in the Swedish market (4.78%).

Stable Dividend: NGS has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: NGS's dividend payments have increased, but the company has only paid a dividend for 7 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (44.4%), NGS's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

What is the CEO of NGS Group's salary, the management and board of directors tenure and is there insider trading?

7.8yrs

Average board tenure


CEO

Ingrid Nordlund (51yo)

11.8yrs

Tenure

kr3,479,893

Compensation

Ms. Ingrid Nordlund has been the Chief Executive Officer of NGS Group AB (publ) since 2008. Ms. Nordlund is a Director of Transcendent Group AB (publ) since 2018. Ms. Nordlund serves as the Chairman of the ...


CEO Compensation Analysis

Compensation vs. Market: Ingrid's total compensation ($USD0.00) is too low to compare against companies of similar size in the Swedish market ($USD124.61K).

Compensation vs Earnings: Ingrid's compensation has been consistent with company performance over the past year.


Board Age and Tenure

7.8yrs

Average Tenure

66yo

Average Age

Experienced Board: NGS's board of directors are considered experienced (7.8 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Charlotte Pantzar Huth (51yo)

    Chief Marketing Officer

    • Tenure: 0yrs
    • Compensation: kr66.67k
  • Ingrid Nordlund (51yo)

    Chief Executive Officer

    • Tenure: 11.8yrs
    • Compensation: kr3.48m
  • Klas Wilborg (52yo)

    Chief Financial Officer

    • Tenure: 11.8yrs
  • Elisabeth Moller

    Head of Sales - Nurse Partner

    • Tenure: 0yrs
  • Malin Ernestrand

    Chief Executive Officer of Nurse Partner

    • Tenure: 0yrs
  • Malin Brolin

    Head of Operations - Care

    • Tenure: 0yrs
  • Thérèse Reimer

    Head of Operations - School

    • Tenure: 0yrs
  • Anders Sandvik

    Head of Operations & Human Resources - School

    • Tenure: 0yrs
  • Johnny Kreft

    Head of Sales - VO Care

    • Tenure: 0yrs

Board Members

  • Ulf Barkman (62yo)

    Director

    • Tenure: 3.8yrs
    • Compensation: kr25.00k
  • Per Odgren (78yo)

    Chairman

    • Tenure: 18.8yrs
    • Compensation: kr200.00k
  • Orvar Pantzar (80yo)

    Director

    • Tenure: 18.8yrs
  • Bertil Johanson (70yo)

    Director

    • Tenure: 6.8yrs
    • Compensation: kr319.25k
  • Malin Schmidt (55yo)

    Director

    • Tenure: 6.8yrs
    • Compensation: kr100.00k
  • Gunilla Carlsson (56yo)

    Director

    • Tenure: 8.8yrs
    • Compensation: kr125.00k

Company Information

NGS Group AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: NGS Group AB (publ)
  • Ticker: NGS
  • Exchange: OM
  • Founded:
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: kr193.992m
  • Shares outstanding: 9.02m
  • Website: https://www.ngsgroup.se

Location

  • NGS Group AB (publ)
  • Holländargatan 13
  • Stockholm
  • Stockholm County
  • 111 36
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NGSOM (OMX Nordic Exchange Stockholm)YesCommon SharesSESEKFeb 2007

Biography

NGS Group AB (publ) operates as a staffing and consulting company in the healthcare, school, social services, finance, management, and leadership areas in Sweden, Norway, and Finland. It offers recruitment ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/14 20:43
End of Day Share Price2019/10/14 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.